At #iwCART25 earlier this year, we brought together leading experts Yi Lin, Rakesh Popat, Doris Hansen, & Sham Mailankody to discuss practical considerations for using T-cell engagers in #MultipleMyeloma.🩸

Watch here:

👉 buff.ly/F53yhJB 👈

#MMSM #Myeloma #ImmunoOnc #CARTCell #BloodSky #MedSky

In a fantastic discussion at #iwCART25 earlier this year, experts David Miklos, Frederick Locke, Lazaros Lekakis, & Sarah Nikiforow shared insights into the application of cell therapy to autoimmune diseases.

Click here to watch:
👉 buff.ly/AUZp3Cb 👈

#Hematology #CARTCell #BloodSky #HemeSky #MedSky

🎥 At #iwCART25, @krishpatelmd.bsky.social‬, Tara Graff, & Caron Jacobson shared their perspectives on how to improve access & delivery of T-cell engaging therapies (CAR-T and bispecifics) in the community.

Watch the discussion here:
👉 buff.ly/4s5IV1D

#HemOnc #CARTCell #ImmunoOnc #MedSky

Watch our exclusive discussion from #iwCART25 with experts Elizabeth Budde, Mohammad Rashidian, Michael Jain, & Marco Ruella to hear about potential strategies being explored to improve efficacy & minimize toxicity of #CARTCell therapy 💉🩸:

🎥 buff.ly/4vlyIE1

#ImmunoOnc #HemOnc #BloodSky #MedSky

What is the current role of T-cell engagers and CARs in myeloid malignancies?🩸

Find out by watching our exclusive expert discussion from #iwCART25 with David Sallman, Marion Subklewe, Jae Park, & Andrew Kuykendall here:

👉 buff.ly/mQBv32R

#AMLsm #Leusm #MPNsm #ImmunoOnc #HemeSky #BloodSky

Want the latest expert insights about CAR-T in ALL?💉🩸

Then check out our recent discussion from #iwCART25, in which leading experts Claire Roddie, Rebecca Gardner, Bijal Shah, & Noelle Frey provide their insights:

👉 buff.ly/Evw2bXJ

#ALLsm #Leusm #CARTCell #HemOnc #BloodSky #HemeSky #MedSky

It's fantastic to see #CARTCell therapy breaking into the field of #Neurology!💉🧠

At #iwCART25, Ali Habib discussed the potential of CAR-T in the treatment of #MyastheniaGravis.

Watch the exclusive interview here:
👉 buff.ly/D3fHnrG 👈

#Autoimmune #Neuroscience #MedSky

What work is being done to accelerate #CARTCell therapeutics using small molecules & CRISPR 2.0 gene editing?💉🧬

Dr Michael Hudecek provided insight into this at #iwCART25 a few weeks ago – watch the interview to learn more:

🎥 buff.ly/sGe1eBq

#ImmunoOnc #HemOnc #CART #BloodSky #HemeSky

Talking IMA203 & SUPRAME trial #iwCART25 in Miami last wknd. Pass the word to #melanoma patients needing novel therapeutics. After ICI, this therapy has possibility for long-term dz control! Trial opening in USA & Europe. 1st pt got IMA203 in Pittsburgh last week!
clinicaltrials.gov/study/NCT067...

#iwCART25 day 1 covered current state of #CellTherapy in solid tumors, CLL & ALL. Day 2 opens with activities in the next frontier: autoimmune disorders. @vjhemonc.bsky.social keynote speaker Dr. David Porter.

An entire day for solid tumor at #iwCART25! How far we’ve come in solid tumor cell therapy- 2 approvals since I was at this meeting last year! Looking forward to a great meeting.